Brief: Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer

Poseida Therapeutics

08/01/2025 06:17

Jan 8 (Reuters) - ROCHE HOLDING AG  ROG.S :
    * ROCHE PURCHASES SHARES IN TENDER OFFER FOR POSEIDA
THERAPEUTICS,
INC.
    * ACCEPTS PAYMENT FOR POSEIDA SHARES AT $9.00 PER SHARE PLUS
CVR
    * TENDER OFFER EXPIRED ON 7 JANUARY 2025, WAS NOT EXTENDED
    * APPROXIMATELY 64,991,586 SHARES OF POSEIDA TENDERED,
REPRESENTING 66.11% OF OUTSTANDING SHARES
    * FOLLOWING COMPLETION OF MERGER, POSEIDA WILL BECOME A
WHOLLY
OWNED SUBSIDIARY OF ROCHE
    * POSEIDA'S SHARES WILL CEASE TO BE TRADED ON NASDAQ GLOBAL
SELECT
MARKET
    * LATER TODAY, ROCHE INTENDS TO COMPLETE ACQUISITION OF
POSEIDA
THROUGH A MERGER OF BLUE GIANT ACQUISITION CORP. WITH AND INTO
POSEIDA

Source text:  ID:nGNE24Y9T1 
Further company coverage:  ROG.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))